Abstract
BackgroundMetabolic syndrome (MetS) is a public health problem in Europe, affecting all age groups. Several MetS definitions are available. The aim of this study was to compare four different MetS definitions in the Finnish adult population, to assess their agreement and to evaluate the impact of the choice of the definition on the prevalence of MetS.MethodsData from FinHealth 2017, a cross-sectional national population health survey, focusing on adults aged 25 years or older were used in the analysis (n=5687). Measured data on anthropometrics, blood pressure and biomarkers together with questionnaire data were used to classify the participants into the MetS categories according to the four definitions. The definitions chosen for the comparison were those by the World Health Organization (WHO) (1998), National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) (2004), International Diabetes Federation (IDF) (2005), and Joint Interim Statement (JIS) (2009).ResultsThe four MetS definitions resulted in substantially different MetS prevalence: 17.7% by WHO, 33.3% by NCEP-ATP III, 41.5% by IDF, and 43.0% by JIS. Regardless of the definition used, the prevalence of MetS increased with age. The prevalence of the different components varied between the definitions, depending on the different cut-off points adopted. Out of all participants, only 13.6% were identified to have MetS according to all four definitions. Agreement between participants recognised by different MetS definitions, estimated through kappa coefficients, was almost perfect for IDF vs. JIS (0.97), strong for JIS vs. NCEP-ATP III (0.80), moderate for IDF vs. NCEP-ATP III (0.76) and weak for WHO vs. NCEP-ATP III (0.42), WHO vs. IDF (0.41) and WHO vs. JIS (0.40).ConclusionsDifferences between observed prevalence of MetS in Finnish men and women using different MetS definitions were large. For cross-country comparisons, as well as for trend analyses within a country, it is essential to use the same MetS definition to avoid discrepancies in classification due to differences in used definitions.
Highlights
Metabolic syndrome (MetS) is a public health problem in Europe, affecting all age groups
The total prevalence was highest for the Joint Interim Statement (JIS) and International Diabetes Federation (IDF) definitions (43.0% for JIS and 41.5% for IDF), while the biggest difference was found between JIS (43.0%) and World Health Organization (WHO) (17.7%)
The highest agreement was observed between IDF and JIS (k=0.97, 95% confidence interval (CI) 0.96-0.97)
Summary
Metabolic syndrome (MetS) is a public health problem in Europe, affecting all age groups. Metabolic syndrome (MetS) is an increasing public health concern globally [1,2,3]. While the pathogenic mechanisms remain under debate, it has been suggested that chronic inflammation might be an underlying mechanism in the development of MetS [11]. This hypothesis is in line with the concept of metaflammation (metabolic inflammation resulting from nutrient excess) that contributes to the pathogenesis of insulin resistance and cardiometabolic diseases [12]. Environmental chemical exposure has been suggested to play a role in the increasing global MetS trend [16, 17]
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have